A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC

Clinical trial NCT06699121 · RECRUITING

Trial details

NCT number: NCT06699121
Sponsor: LISCure Biosciences
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Sclerosing Cholangitis (PSC)

Start date: 2025-11-01
Primary completion: 2028-03-01
Enrollment: 87

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.